Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework.
Naicker S, Roberts JA, Won H, Wallis SC, Unwin S, Jamieson C, Hills T, Gilchrist M, Santillo M, Seaton RA, Drummond F, Sime FB. Naicker S, et al. Among authors: seaton ra. JAC Antimicrob Resist. 2024 Apr 5;6(2):dlae056. doi: 10.1093/jacamr/dlae056. eCollection 2024 Apr. JAC Antimicrob Resist. 2024. PMID: 38585225 Free PMC article.
Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy.
Jamieson C, Drummond F, Hills T, Ozolina L, Gilchrist M, Seaton RA, Santillo M, Wilkinson AS, Allwood MC. Jamieson C, et al. Among authors: seaton ra. JAC Antimicrob Resist. 2021 Sep 27;3(3):dlab141. doi: 10.1093/jacamr/dlab141. eCollection 2021 Sep. JAC Antimicrob Resist. 2021. PMID: 34676364 Free PMC article.
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document.
Sime FB, Wallis S, Jamieson C, Hills T, Gilchrist M, Santillo M, Seaton RA, Drummond F, Roberts J; BSAC Drug Stability Testing Programme. Sime FB, et al. Among authors: seaton ra. Eur J Hosp Pharm. 2023 Mar;30(e1):e76-e81. doi: 10.1136/ejhpharm-2022-003286. Epub 2022 May 24. Eur J Hosp Pharm. 2023. PMID: 35609967 Free PMC article.
Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT).
Gilchrist M, Jamieson C, Drummond F, Hills T, Seaton RA, Santillo M. Gilchrist M, et al. Among authors: seaton ra. JAC Antimicrob Resist. 2023 Apr 17;5(2):dlad047. doi: 10.1093/jacamr/dlad047. eCollection 2023 Apr. JAC Antimicrob Resist. 2023. PMID: 37077650 Free PMC article. No abstract available.
Assessment of the stability of citrate-buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements.
Jamieson C, Ozolina L, Seaton RA, Gilchrist M, Hills T, Drummond F, Wilkinson AS; BSAC Drug Stability Testing Working Group. Jamieson C, et al. Among authors: seaton ra. Eur J Hosp Pharm. 2022 Jul;29(4):212-216. doi: 10.1136/ejhpharm-2020-002340. Epub 2020 Sep 25. Eur J Hosp Pharm. 2022. PMID: 32978220 Free PMC article.
Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK.
Chapman ALN, Patel S, Horner C, Green H, Guleri A, Hedderwick S, Snape S, Statham J, Wilson E, Gilchrist M, Seaton RA. Chapman ALN, et al. Among authors: seaton ra. JAC Antimicrob Resist. 2019 Aug 26;1(2):dlz026. doi: 10.1093/jacamr/dlz026. eCollection 2019 Sep. JAC Antimicrob Resist. 2019. PMID: 34222901 Free PMC article. Review.
142 results